RxDoctor Payments DataLook up a doctor →

Mohan Kesani, MD

Cardiovascular Disease · Munster, INNPI 1578513362

Payments from drug & device makers

$1,169,908in general payments, 2019–2025

Across 613 payments — averaging $1908.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$805K
  • Boehringer Ingelheim International GmbH$186K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$52K
  • AstraZeneca$49K
  • Janssen Research & Development, LLC$28K
  • Verona Pharma, Inc.$21K
  • plus $30K from 51 others
$6,062in research payments, 2019–2025

Across 12 payments — averaging $505.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$4K
  • GSK$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$804,803
Boehringer Ingelheim International GmbH77$185,974
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)43$51,705
AstraZeneca26$48,555
Janssen Research & Development, LLC11$28,076
Verona Pharma, Inc.3$20,619
Insmed, Inc.24$15,720
Novartis110$2,413
Genentech USA, Inc.5$2,062
Johnson & Johnson35$1,177
Amgen(2 entities)25$942
Novo Nordisk14$798
Boehringer Ingelheim30$736
E.r. Squibb & Sons, L.L.C.21$600
Merck25$508
Boston Scientific5$479
Sanofi-aventis U.S. LLC22$442
Medtronic(2 entities)11$431
Kestra Medical Technology Services, Inc.12$328
Actelion Pharmaceuticals US, Inc.8$263
Angiodynamics, Inc.3$221
Lilly USA, LLC3$210
Abbott3$208
Philips North America LLC2$179
Vifor Pharma, Inc.8$169
Lexicon Pharmaceuticals, Inc.4$164
Chiesi USA, Inc.4$153
Cook Medical LLC1$137
Penumbra, Inc.1$137
Tactile Systems Technology Inc6$127
Alnylam Pharmaceuticals Inc.5$125
Heartflow, Inc.3$106
Lundbeck LLC7$101
Regeneron Healthcare Solutions, Inc.5$101
Surmodics, Inc.1$99
AbbVie1$98
Nuwellis, Inc.1$97
Biotronik Inc.1$97
Scpharmaceuticals Inc.4$83
Baxter Healthcare2$79
Esperion Therapeutics, Inc.5$78
Edwards Lifesciences4$72
Cardiovascular Systems Inc.6$65
Pfizer3$59
Astellas Pharma US Inc2$45
Kiniksa Pharmaceuticals International, PLC3$45
W. L. Gore & Associates, Inc.2$34
Bayer2$27
Amarin Pharma, Inc.2$27
Itamar Medical Inc1$25
Lantheus Medical Imaging, Inc.1$23
Cvrx, Inc.1$23
Kerecis Limited1$14
Vivaquant Inc, Dba Rhythm Express1$13
Arbor Pharmaceuticals, Inc.1$12
Siemens Medical Solutions USA, Inc.1$12
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$1,169,908 in reported general payments places this provider in the 95th percentile of 408 cardiovascular disease providers in Indiana.

See all cardiovascular disease providers in Indiana

Medicare billing

Part B allowed, 2024
$727,556
Medicare patients
974
Services billed
5,934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →